Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2381767 Title: FORMULATION DE RASAGILINE À LIBÉRATION RETARDÉE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
107337313
WO application number:
US2010000174
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2381767
WO publication number:
WO2010085354
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
21/01/2010
Grant date:
20/01/2016
EP publication date:
02/11/2011
WO publication date:
29/07/2010
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
20/01/2016
EP B1 publication date:
20/01/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
21/01/2030

Applicant

Name:
Teva Pharmaceutical Industries Ltd.
Legal Form:
From:
20/01/2016
Address:
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva, Israel (IL)
To:

Inventor

1

Name:
SAFADI, Muhammad
Legal Form:
Address:
16164 Nazareth, Israel (IL)

2

Name:
LICHT, Daniella
Legal Form:
Address:
54041 Givat-shmuel, Israel (IL)

3

Name:
COHEN, Rachel
Legal Form:
Address:
38100 Hadera, Israel (IL)

4

Name:
FRENKEL, Anton
Legal Form:
Address:
42268 Netanya, Israel (IL)

5

Name:
KOLTAI, Tamas
Legal Form:
Address:
42758 Netanya, Israel (IL)

6

Name:
ZHOLKOVSKY, Marina
Legal Form:
Address:
59496 Bat-yam, Israel (IL)

Priority

1

Priority patent number:
689044
Priority date:
18/01/2010
Priority country:
United States (US)

2

Priority patent number:
456029
Priority date:
09/06/2009
Priority country:
United States (US)

3

Priority patent number:
456001
Priority date:
09/06/2009
Priority country:
United States (US)

4

Priority patent number:
456031
Priority date:
09/06/2009
Priority country:
United States (US)

5

Priority patent number:
205833 P
Priority date:
23/01/2009
Priority country:
United States (US)

6

Priority patent number:
455976
Priority date:
09/06/2009
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 9/20; A61K 31/135;

Publication

European Patent Bulletin

Issue number:
201603
Publication date:
20/01/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/08/2016
Annual fee number:
7
Annual fee amount:
110 Euro
Penalty fee amount:
85 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type